Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1479, 2005-01, pp. : 4-4
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Gemcitabine + vinorelbine: superior to platinum-based regimens in NSCLC?
Inpharma, Vol. 1, Iss. 1308, 2001-01 ,pp. :
Access to resources
Recommend
Time to abandon `best supportive care' as a standard of care for NSCLC?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 283, 2000-01 ,pp. :
Time to consider placebo effect in QOL studies in NSCLC?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 327, 2001-01 ,pp. :
RRM1-based tailored chemotherapy for NSCLC?
Inpharma, Vol. 1, Iss. 1432-1433, 2004-01 ,pp. :
Polymorphisms: prognostic factors in advanced NSCLC?
Inpharma, Vol. 1, Iss. 1454, 2004-01 ,pp. :